---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-010484"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-06-30T23:59:59+00:00"
generated_at: "2026-06-24T21:54:29.767711+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CytoDyn raises $21.8M in private placement; appoints Cyrus Arman as President

## Summary
- Raised ~$21.8M gross via ~85.4M units at $0.255/unit; each unit = 1 share + 3/4 warrant (5-yr term).
- Cyrus Arman, Ph.D. appointed President effective July 9, 2022; replaces interim President Migliarese who stays CFO.
- Arman's base salary $458K, target bonus 40%, equity grants (options $750K, RSUs/PSUs $375K) subject to shareholder vote.
- Placement agent receives 13% cash fee + ~19.4M warrants (10-yr) subject to shareholder approval of authorized share increase.
- Issued 43,657 shares to former executive for severance obligation of $15,523.

## SEC filing metadata
- accession: 0001558370-22-010484
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/cydy-20220624x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-010484
- JSON: https://secwatch.observer/filing/0001558370-22-010484.json
- Plain text: https://secwatch.observer/filing/0001558370-22-010484.txt

## Key facts
- Executive change
  Antonio Migliarese changed role as Chief Financial Officer, Corporate Secretary and Treasurer at CytoDyn Inc..
  - Action: ceased to be President
  - Role: Chief Financial Officer, Corporate Secretary and Treasurer
  source text: Antonio Migliarese, who was appointed as interim President on January 24, 2022, will cease to be President on July 9, 2022, but will continue in his roles of Chief Financial Officer, Corporate Secretary and Treasurer, as well as serving as the Company’s principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm
- Executive change
  Cyrus Arman was appointed as President at CytoDyn Inc..
  - Action: appointed
  - Role: President
  source text: entered into an employment agreement with Cyrus Arman, Ph.D. (the “Employment Agreement”), under which he will be employed as the Company’s President on an at-will basis beginning on July 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.